William Tillett

From the Royal National Hospital for Rheumatic Diseases;Toronto Western Hospital;Toronto Western Research Institute University Health Network;St. Vincent's University Hospital;Quintiles;School of Medicine, Duke University;Durham;Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds;Chapel Allerton Hospital;Université Pierre et Marie Curie-Paris 6, UPMC Univ Paris 6);Department of Rheumatology, Pitié Salpêtrière Hospital;Division of Rheumatology, Johns Hopkins University School of Medicine;Division of Immunology/Rheumatology, Stanford University School of Medicine;University of Bath;Swedish Medical Center, University of Washington;Royal National Hospital for Rheumatic Diseases, the University of Pennsylvania;Toronto Western Hospital;M. de Wit, OMERACT Patient Research Partner;Toronto Western Research Institute, University Health Network;FRCPI, St. Vincent's University Hospital;School of Medicine, Quintiles, and Duke University;W. Campbell;Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds;UPMC Univ Paris 6, Sorbonne Universités;Division of Rheumatology, Johns Hopkins University School of Medicine;A. Ogdie;School of Medicine, Stanford University;Royal National Hospital for Rheumatic Diseases, University of Bath;Swedish Medical Center, University of Washington;Duke University, University of Leed

Claim

基本信息

Career Trajectory

Bio

Dr Tillett is an honorary consultant rheumatologist at the Royal National Hospital for Rheumatic Diseases and senior lecturer in the department of Pharmacy and Pharmacology and Centre for Therapeutic Innovation at the University of Bath, UK. He graduated from the University of Bristol with a BSc in Anatomical Science before undertaking his medical degree at the same institution. He undertook his doctoral fellowship in outcome measurement in psoriatic arthritis.

Research Interests

Papers共 343 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from 2 Phase III Studies

Dafna D Gladman,Philip J Mease,Laure Gossec,M Elaine Husni,Alice B Gottlieb,Barbara Ink,Rajan Bajracharya,Jason Coarse,Nikos Lyris,Jérémy Lambert,William Tillett

The Journal of rheumatologyno. 5 (2025): 466-478

Cited0Views0WOSBibtex

Diagnostic Delay and Less Intensive Therapy for People with Psoriatic Arthritis Compared with Rheumatoid Arthritis: a Study Nested Within an English and Welsh Audit Data Set

Rachel A Charlton, Emer Gates,Laura C Coates,James Galloway,Neil McHugh,Anita McGrogan,Simon Hackett, Melanie Brooke, Charlotte Cavill,William Tillett

Annals of the rheumatic diseasesno. 6 (2025): 970-978

Cited0Views0WOSBibtex

An Interpretable Machine Learning Approach for Detecting Psoriatic Arthritis in a UK Primary Care Psoriasis Cohort Using Electronic Health Records from the Clinical Practice Research Datalink

Alexander Rudge,Neil McHugh,William Tillett,Theresa Smith

Annals of the rheumatic diseasesno. 4 (2025): 575-583

Cited0Views0WOSBibtex

Identification of Distinct Disease Activity Trajectories in Patients with Psoriatic Arthritis Receiving Tofacitinib: a Post Hoc Analysis of Two Phase 3 Studies

Dafna Gladman,William Tillett,David Gruben, Laura C Coates, Stefanie Hahne, Mikhail Volkov

RMD openno. 2 (2025)

Cited0Views0WOSBibtex

The Use of Combination Advanced Therapies in Psoriatic Arthritis: Results from a UK Multi-Centre Audit

Hannah Jethwa,Tania Gudu,Laura C Coates,Philip S Helliwell,William Tillett, Abdalla Abuelmagd, Rajinder S Andev, Madiha Ashraf, Tanya Baqai,Ernest Choy,Dhivya Das,Nicola Gullick, Catherine Heighton,Alison Kinder,Ramasharan Laxminarayan, Gayatri Mittal, Penelope Morris, Sandeep Mukherjee,Anupama Nandagudi,Satyapal Rangaraj,Poonam Sharma, Hoda Temple, Beverly Traub, Vishal Paisal, Ryan Hum,Arani Vivekanantham, Robert Wilson,Deepak Jadon

Rheumatology (Oxford, England)no. 5 (2025): 3173-3176

Cited0Views0WOSBibtex

POS0961 BIMEKIZUMAB MAINTAINED EFFICACY RESPONSES THROUGH 52 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES

Tillett W., Tanaka Y.,Thaçi D.,Ink B.,Taieb V., Edens H.,Bajracharya R.,Walsh J.A.

Annals of the Rheumatic Diseases (2024): 691-692

Cited0Views0Bibtex

Enhanced Surveillance for the Detection of Psoriatic Arthritis in a UK Primary Care Psoriasis Population: Results from the TUDOR Trial

Neil McHugh,William Tillett,Philip Helliwell,Jonathan Packham,Howard Collier, Claire Davies,Myka Ransom,Laura Coates,Sarah T. Brown

RHEUMATOLOGY (2024)

Cited0Views0WOSBibtex

POS0964 DYNAMIC PREDICTION OF PSORIATIC ARTHRITIS IN A COHORT OF PSORIASIS PATIENTS USING UK PRIMARY CARE ELECTRONIC HEALTH RECORDS

Rudge A.,Mchugh N.,Tillett W., Smith T.

Annals of the Rheumatic Diseases (2024): 699-700

Cited0Views0Bibtex

Comparaison De L’efficacité Précoce (3 Mois) Et Maintenue (12 Mois) De 5 Classes Thérapeutiques Différentes Dans Une Grande Cohorte Multinationale De Patients Atteints De Rhumatisme Psoriasique En Vie Réelle

W. Tillett,R. Alten,E. Lubrano, K.J. Ng, M. Ngantcha,I. De La Torre, D. Kennedy,N. Gullick, D. McGonagle,J. Morel

Revue du Rhumatisme (2024): A107-A108

Cited0Views0Bibtex

BIMEKIZUMAB MAINTAINED EFFICACY RESPONSES THROUGH 52 WEEKS IN BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGNAIVE PATIENTS WITH PSORIATIC ARTHRITIS WHO WERE RESPONDERS AT WEEK 16: RESULTS FROM BE OPTIMAL, A PHASE 3, ACTIVEREFERENCE STUDY

William R. Tillett,Joseph F. Merola,Yoshiya Tanaka,Ennio G. Favalli,Dennis McGonagle,Jessica A. Walsh,Diamant Thaci,Barbara Ink,Rajan Bajracharya,Vanessa Taieb,Christopher T. Ritchlin

RHEUMATOLOGY (2024)

Cited0Views0Bibtex

Author Statistics

#Papers: 344

#Citation: 3019

H-Index: 29

G-Index: 51

Sociability: 7

Diversity: 2

Activity: 516

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn